Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Contineum Therapeutics (CTNM) Other Non-Current Liabilities: 2023

Historic Other Non-Current Liabilities for Contineum Therapeutics (CTNM) over the last 1 years, with Dec 2023 value amounting to $110,000.

  • Contineum Therapeutics' Other Non-Current Liabilities was N/A to $228,000 in Q1 2024 from the same period last year, while for Mar 2024 it was $228,000, marking a year-over-year change of. This contributed to the annual value of $110,000 for FY2023, which is N/A change from last year.
  • According to the latest figures from FY2023, Contineum Therapeutics' Other Non-Current Liabilities is $110,000.
  • Contineum Therapeutics' Other Non-Current Liabilities' 5-year high stood at $110,000 during FY2023, with a 5-year trough of $110,000 in FY2023.
  • Moreover, its 1-year median value for Other Non-Current Liabilities was $110,000 (2023), whereas its average is $110,000.